These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6301281)

  • 1. In vitro study of phosphodiesterase-inhibiting drugs: a complement to beta-sympathomimetic drug therapy in premature labor?
    Berg G; Andersson RG; Rydén G
    Am J Obstet Gynecol; 1983 Apr; 145(7):802-6. PubMed ID: 6301281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective beta-adrenergic agonists on spontaneous contractions, cAMP levels and phosphodiesterase activity in myometrial strips from pregnant women treated with terbutaline.
    Berg G; Andersson RG; Rydén G
    Gynecol Obstet Invest; 1982; 14(1):56-64. PubMed ID: 6288517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different phosphodiesterase-inhibiting drugs on human pregnant myometrium: an in vitro study.
    Berg G; Andersson RG; Ryden G
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):288-92. PubMed ID: 3446047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro.
    Verli J; Klukovits A; Kormányos Z; Hajagos-Tóth J; Ducza E; Seres AB; Falkay G; Gáspár R
    J Obstet Gynaecol Res; 2013 Jan; 39(1):31-9. PubMed ID: 22765375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the relaxing effect of beta-adrenergic agonists on the human myometrium only transitory?
    Rydén G; Andersson RG; Berg G
    Acta Obstet Gynecol Scand Suppl; 1982; 108():47-51. PubMed ID: 6289597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
    Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
    Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
    Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of four tocolytic agents, alone and in combination.
    Saade GR; Taskin O; Belfort MA; Erturan B; Moise KJ
    Obstet Gynecol; 1994 Sep; 84(3):374-8. PubMed ID: 8058234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the relaxing effect of terbutaline with phosphodiesterase inhibitors: studies on pregnant rat uteri in vitro.
    Klukovits A; Verli J; Falkay G; Gáspár R
    Life Sci; 2010 Dec; 87(23-26):733-7. PubMed ID: 20970435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the effect of nifedipine in the pregnant rat myometrium: the influence of progesterone and terbutaline.
    Hajagos-Tóth J; Falkay G; Gáspár R
    Life Sci; 2009 Oct; 85(15-16):568-72. PubMed ID: 19703476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Indomethacin on cyclic AMP phosphodiesterase activity in myometrium from pregnant rhesus monkeys.
    Beatty CH; Bocek RM; Young MK; Novy MJ
    Prostaglandins; 1976 Apr; 11(4):713-25. PubMed ID: 183237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
    Bardou M; Rouget C; Breuiller-Fouché M; Loustalot C; Naline E; Sagot P; Frydman R; Morcillo EJ; Advenier C; Leroy MJ; Morrison JJ
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S14. PubMed ID: 17570158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human cyclic AMP phosphodiesterase by uterine relaxant drugs.
    Ferre F; De Pariente D; Breuiller M; Cedard L
    Biochem Pharmacol; 1978; 27(8):1292-4. PubMed ID: 212084
    [No Abstract]   [Full Text] [Related]  

  • 15. PDE4 as a target in preterm labour.
    Méhats C; Schmitz T; Oger S; Hervé R; Cabrol D; Leroy MJ
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S12. PubMed ID: 17570156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of terbutaline in preterm labor.
    Solum T
    Acta Obstet Gynecol Scand Suppl; 1982; 108():37-8. PubMed ID: 6957126
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after beta-mimetic treatment.
    Berg G; Andersson RG; Rydén G
    Am J Obstet Gynecol; 1985 Feb; 151(3):392-6. PubMed ID: 2982269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 2-nicotinamidethyl nitrate (SG-75), a new antianginal drug, on the cyclic AMP phosphodiesterase activity.
    Endoh M; Yanagisawa T; Taira N
    Tohoku J Exp Med; 1980 Feb; 130(2):199-201. PubMed ID: 6247783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.